Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLRN | AZN | AMGN | GILD | VRTX |
| Company | Acelyrin Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.24 | 163.52 | 437.89 | 149.47 | 547.09 |
| High | 2.36 | 163.54 | 437.89 | 149.47 | 549.57 |
| Low | 2.20 | 161.18 | 430.72 | 144.88 | 540.08 |
| Last | 2.27 | 162.70 | 432.42 | 145.68 | 541.69 |
| Change | +0.04 | -1.82 | -4.57 | -3.18 | -5.86 |
| Percent Change | +1.79% | -1.11% | -1.05% | -2.14% | -1.07% |
| Volume | 4,076,500 | 2,880,800 | 1,739,900 | 3,946,900 | 886,900 |
| 20-Day Average Volume | 1,091,300 | 4,408,400 | 2,575,965 | 6,338,855 | 1,200,375 |
| Previous | 2.23 | 164.52 | 436.99 | 148.86 | 547.55 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.33 | 161.63 | 421.46 | 140.05 | 521.85 |
| 20-Day Raw Stochastic | 45.16% | 55.39% | 79.44% | 80.87% | 84.48% |
| 20-Day Relative Strength | 47.29 | 44.81 | 64.96 | 60.44 | 61.38 |
| Weighted Alpha | -28.45 | -6.09 | +54.63 | +28.38 | +41.13 |
| Today's Opinion | 88% Sell | 88% Sell | 100% Buy | 72% Buy | 100% Buy |
| Yesterday's Opinion | 88% Sell | 88% Sell | 100% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 88% Sell | 100% Buy | 24% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.61% since 05/13/25 | -1.98% since 08/21/26 | -1.57% since 08/21/26 | -0.30% since 08/21/26 | -1.16% since 08/21/26 |
| Low | 1.95 on 05/15/25 | 161.18 on 08/28/26 | 430.72 on 08/28/26 | 144.59 on 08/24/26 | 540.08 on 08/28/26 |
| High | 2.36 on 05/20/25 | 170.18 on 08/25/26 | 447.03 on 08/25/26 | 149.62 on 08/26/26 | 555.69 on 08/25/26 |
| 1-Month | |||||
| %Chg | +3.18% since 04/17/25 | -5.67% since 07/28/26 | +10.00% since 07/28/26 | +8.46% since 07/28/26 | +10.46% since 07/28/26 |
| Low | 1.95 on 05/15/25 | 153.41 on 08/03/26 | 375.96 on 08/03/26 | 128.28 on 07/30/26 | 465.51 on 08/04/26 |
| High | 2.65 on 05/01/25 | 175.04 on 07/29/26 | 447.03 on 08/25/26 | 149.62 on 08/26/26 | 555.69 on 08/25/26 |
| 3-Month | |||||
| %Chg | +4.61% since 02/20/25 | -12.21% since 05/28/26 | +28.51% since 05/28/26 | +6.94% since 05/28/26 | +20.92% since 05/28/26 |
| Low | 1.95 on 05/15/25 | 153.41 on 08/03/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 2.94 on 04/02/25 | 196.41 on 07/02/26 | 447.03 on 08/25/26 | 149.62 on 08/26/26 | 555.69 on 08/25/26 |
| 6-Month | |||||
| %Chg | -48.76% since 11/20/24 | -21.95% since 02/27/26 | +11.40% since 02/27/26 | -2.20% since 02/27/26 | +9.03% since 02/27/26 |
| Low | 1.85 on 02/11/25 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 5.03 on 11/25/24 | 207.30 on 04/10/26 | 447.03 on 08/25/26 | 150.77 on 03/02/26 | 555.69 on 08/25/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 229,166 | 252,332,720 | 233,780,096 | 180,636,624 | 137,483,632 |
| Shares Outstanding, K | 100,954 | 1,550,908 | 540,632 | 1,239,955 | 253,805 |
| Annual Sales, $M | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income, $M | -248,230,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Qtr Sales, $M | 0 | 15,384,000,000 | 10,054,000,000 | 7,803,000,000 | 3,333,900,000 |
| Last Qtr Income, $M | -55,260,000 | 2,507,000,000 | 2,375,000,000 | -10,496,000,000 | 1,099,800,000 |
| 60-Month Beta | 1.07 | 0.26 | 0.41 | 0.32 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 05/14/25 | 2.63 on 07/27/26 | 6.29 on 08/04/26 | -6.75 on 08/04/26 | 4.73 on 08/03/26 |
| Latest Earnings Date | 08/12/25 | 11/05/26 | 11/03/26 | 10/29/26 | 11/02/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 08/21/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 09/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.94 | 19.53 | 0.00 | 32.17 |